| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000018488 |
| Receipt No. | R000020461 |
| Official scientific title of the study | Evaluation of intubation efficacy evaluation with or without stylet |
| Date of disclosure of the study information | 2015/07/31 |
| Last modified on | 2016/05/11 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Evaluation of intubation efficacy evaluation with or without stylet | |
| Title of the study (Brief title) | Intubation efficacy evaluation with or without stylet | |
| Region |
|
|
| Condition | ||
| Condition | Patient who undergo general anesthesia | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluation of stylet for tracehal intubation |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Intubation time
times of laryngoscopy progression time |
| Key secondary outcomes | Patient characteristics |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Tracehal intubation with stylet | |
| Interventions/Control_2 | Tracheal intubation without stylet | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patient who undergo general anesthesia | |||
| Key exclusion criteria | Crash induction
Prone DLT |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Nobuyasu Komasawa |
| Organization | Osaka Medical College |
| Division name | Anesgthesiology |
| Address | 2-7 Daigaku-machi, Takatsuk city |
| TEL | 0726-84-6361 |
| ane078@poh.osaka-med.ac.jp | |
| Public contact | |
| Name of contact person | Komasawa Nobuyasu |
| Organization | Osaka Medical College |
| Division name | Anesthesiology |
| Address | 2-7Daigaku-machi, Takatsuki city |
| TEL | 0726-84-6361 |
| Homepage URL | |
| ane078@poh.osaka-med.ac.jp | |
| Sponsor | |
| Institute | Hokusetsu General Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Hokusetsu General Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | Pharyngeal pain was significantly higher in the stylet group than in the control group. |
| Other related information | There were no sigifnicant difference between the stylet and non-stylet group about the incidence of postoperative hoarseness. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020461 |